Search Results - Henrik Zetterberg

Henrik Zetterberg

Zetterberg with the [[Detroit Red Wings]] in February 2012 Henrik Zetterberg (; born 9 October 1980) is a Swedish former professional ice hockey forward. He played his entire National Hockey League career, from 2002 to 2018, with the Detroit Red Wings of the National Hockey League.

Bursting onto the scene as a rookie in the 2002–03 NHL season, Zetterberg would finish 2nd overall in votes for the Calder Memorial Trophy as the League's top rookie. Along with winning the Stanley Cup in 2008, Zetterberg won the Conn Smythe Trophy as the Most Valuable Player of the 2008 Stanley Cup playoffs. He won gold medals in the 2006 Ice Hockey World Championships and 2006 Winter Olympics, as part of the first team to ever win both tournaments in the same year, also making him a member of the Triple Gold Club. Provided by Wikipedia
  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Tau as a fluid biomarker of concussion and neurodegeneration

    Tau as a fluid biomarker of concussion and neurodegeneration by Iftakher Hossain, Kaj Blennow, Jussi P Posti, Henrik Zetterberg

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Update on fluid biomarkers for concussion

    Update on fluid biomarkers for concussion by Henrik Zetterberg, Huw R Morris, John Hardy, Kaj Blennow

    Published 2016-02-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Losing the identity of a hockey player: the long-term effects of concussions

    Losing the identity of a hockey player: the long-term effects of concussions by Åsa Engström, Eija Jumisko, Pashtun Shahim, Niklas Lehto, Kaj Blennow, Henrik Zetterberg, Yelverton Tegner

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Quality of life of ice hockey players after retirement due to concussions

    Quality of life of ice hockey players after retirement due to concussions by Anna Gard, Niklas Lehto, Åsa Engström, Pashtun Shahim, Henrik Zetterberg, Kaj Blennow, Niklas Marklund, Yelverton Tegner

    Published 2020-08-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia

    Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia by Cassandra Marotta, Fernando Gonzalez‐Ortiz, Michael Turton, Henrik Zetterberg, Peter Harrison, Christopher M. Hovens, Benjamin Sinclair, Terence J. O'Brien, Kaj Blennow, Lucy Vivash

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Investigating the eye in Down syndrome as a window to Alzheimer’s disease: the REVEAL protocol – a clinical cross-sectional study

    Investigating the eye in Down syndrome as a window to Alzheimer’s disease: the REVEAL protocol – a clinical cross-sectional study by Henrik Zetterberg, Tunde Peto, Imre Lengyel, Kathryn Saunders, Sarah Atkinson, André Strydom, Julie-Anne Little, Elaine Murray, Jamie Mitchell, Aoife Mary Louise Hunter, Lajos Csincsik

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest

    Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest by Johannes Lorentzson, Gisela Lilja, Erik Blennow Nordström, Kaj Blennow, Henrik Zetterberg, Christian Hassager, Matt P. Wise, Andrea L. Benedet, Tommaso Pellis, Hans Friberg, Nicholas Ashton, Marion Moseby Knappe

    Published 2025-09-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation

    Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation by Charalampos D. Moschopoulos, Evangelia Stanitsa, Konstantinos Protopapas, Akrivi Vatsi, Irene Galani, Henrik Zetterberg, Ion Beratis, Paraskevi C. Fragkou, Sotirios Tsiodras, Dimitra Kavatha, Antonios Papadopoulos, Sokratis G. Papageorgiou, Anastasia Antoniadou

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline

    The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline by Adam J Paulsen, Ira Driscoll, Brianne M. Breidenbach, Matthew Glittenberg, Sarah R. Lose, Yue Ma, Mark A. Sager, Cynthia M. Carlsson, Catherine L. Gallagher, Bruce P. Hermann, Kaj Blennow, Henrik Zetterberg, Sanjay Asthana, Sterling C. Johnson, Tobey J. Betthauser, Bradley T. Christian, Dane B. Cook, Ozioma C. Okonkwo

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Cerebrospinal fluid YKL‐40 relates to white matter hyperintensity progression in females but not males over a 6‐year period

    Cerebrospinal fluid YKL‐40 relates to white matter hyperintensity progression in females but not males over a 6‐year period by Amalia J. Peterson, Yunyi Sun, Derek B. Archer, Hailey A. Adegboye, Elizabeth E. Moore, Isabella Deberghes, Kimberly R. Pechman, Niranjana Shashikumar, W. Hudson Robb, Abigail W. Workmeister, T. Bryan Jackson, Dandan Liu, Logan Dumitrescu, L. Taylor Davis, Bennett A. Landman, Kaj Blennow, Henrik Zetterberg, Timothy J. Hohman, Angela L. Jefferson

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).

    Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's di... by Howard H Feldman, José A Luchsinger, Gabriel C Léger, Curtis Taylor, Diane M Jacobs, David P Salmon, Steven D Edland, Karen Messer, Carolyn Revta, Sarah A Flowers, Kerry S Jones, Albert Koulman, Kevin E Yarasheski, Philip B Verghese, Venky Venkatesh, Henrik Zetterberg, January Durant, Jody-Lynn Lupo, Gary E Gibson, ADCS BenfoTeam Study Group

    Published 2024-01-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohortResearch in context

    Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohortResearch in context by Moritz Berger, Hector Garcia-Moreno, Mónica Ferreira, Jeannette Hubener-Schmid, Tamara Schaprian, Philipp Wegner, Tim Elter, Kennet M. Teichmann, Magda M. Santana, Marcus Grobe-Einsler, Demet Oender, Berkan S.C. Koyak, Sarah Bernsen, Luís Pereira de Almeida, Patrick Silva, Joana Afonso Ribeiro, Inês Cunha, Cristina Gonzalez-Robles, Shamsher Khan, Amanda Heslegrave, Henrik Zetterberg, Manuela Lima, Mafalda Raposo, Ana F. Ferreira, João Vasconcelos, Bart P. van de Warrenburg, Judith van Gaalen, Teije H. van Prooije, Jeroen de Vries, Ludger Schols, Olaf Riess, Matthis Synofzik, Dagmar Timmann, Andreas Thieme, Friedrich Erdlenbruch, Jon Infante, Ana L. Pelayo-Negro, Leire Manrique, Kathrin Reetz, Imis Dogan, Gulin Oz, James M. Joers, Khalafalla Bushara, Chiadikaobi Onyike, Michal Povazan, Heike Jacobi, Jeremy D. Schmahmann, Eva-Maria Ratai, Matthias Schmid, Paola Giunti, Thomas Klockgether, Jennifer Faber

    Published 2025-08-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: